Evaluation of a Theory-Driven Manualized Approach to Improving New Learning and Memory in MS

CompletedNot a drug-phase studyRelapsing and progressiveNCT03983681

What it found

No results found

We found no results in the registry or in papers.

What was tested

Treatment tested

  • Strategy-Based Training to Enhance Memory (STEM)

Placebo

  • Placebo control exercises

What it measured

Main measures

  • Changes in scores on self-report measure of everyday cognition (subjective)

    Baseline (week 1), immediately post-intervention (week 6) and long-term follow-up (week 6 months post-intervention)

    Thinking and memory
  • Changes in scores on self-report measure of everyday cognition (objective)

    Baseline (week 1), immediately post-intervention (week 6) and long-term follow-up (week 6 months post-intervention)

    Thinking and memory

Other measures (7)

  • Changes in auditory processing speed

    Baseline (week 1), immediately post-intervention (week 6) and long-term follow-up (week 6 months post-intervention)

    Thinking and memory
  • Changes in information processing speed

    Baseline (week 1), immediately post-intervention (week 6) and long-term follow-up (week 6 months post-intervention)

    Thinking and memory
  • Changes in episodic verbal memory and learning

    Baseline (week 1), immediately post-intervention (week 6) and long-term follow-up (week 6 months post-intervention)

    Thinking and memory
  • Changes in visuospatial memory

    Baseline (week 1), immediately post-intervention (week 6) and long-term follow-up (week 6 months post-intervention)

    Thinking and memory
  • Changes in ability in spontaneous production of words

    Baseline (week 1), immediately post-intervention (week 6) and long-term follow-up (week 6 months post-intervention)

  • Changes in visual perception

    Baseline (week 1), immediately post-intervention (week 6) and long-term follow-up (week 6 months post-intervention)

  • Changes in executive function

    Baseline (week 1), immediately post-intervention (week 6) and long-term follow-up (week 6 months post-intervention)

Who could take part

Relapsing and progressive · 18 to 59

Show the full criteria

Inclusion criteria

* Diagnosis of Multiple Sclerosis * Ability to read and speak English fluently * Difficulties with learning and memory skills

Exclusion criteria

* Prior diagnosis of stroke or other neurological injury/disease * Flare up of symptoms within a month of study participation * History of significant psychiatric illness (e.g., bipolar disorder, schizophrenia, psychosis) or current diagnosis of Major Depressive Disorder, Schizophrenia, Bipolar Disorder I or II * Current significant alcohol or substance abuse * Taking exclusionary medication (study team will review medications) For Optional MRI: * Pacemaker or other implanted electrical device, brain stimulator, aneurysm clip (metal clips on the wall of a large artery), metallic prostheses (including metal pins and rods, heart valves, and internal hearing aids [cochlear implants]), permanent eyeliner, implanted delivery pumps, or shrapnel fragments. * Dental implants * Left-handed

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

The purpose of this research study is to investigate the effectiveness of a memory enhancement technique in persons with Multiple Sclerosis.

Papers

    Loading reviews and guidelines…

    History

      1. Started

        Sept 2019

      2. Main results due

        Dec 2025

      3. Finished

        Dec 2025

      Assembled by software from public sources.